<sentence id="0">Inactivation of p16 gene in leukemia .</sentence>
<sentence id="1">To determine the frequency of p16 gene inactivation in leukemia cells , and to evaluate their value in the prediction of their clinical outcome .</sentence>
<sentence id="2">Bone marrow or peripheral blood samples from 48 patients with leukemia were examined by multiplex polymerase chain reaction ( MPCR ) to detect p16 gene homozygous deletion , and restriction enzyme PCR to detect p16 gene methylation .</sentence>
<sentence id="3">p16 gene inactivation were detected in 10 of the 48 patients ( 20.4 % ) .</sentence>
<sentence id="4">They were five patients with p16 homozygous deletion , and five patients with p16 methylation , respectively .</sentence>
<sentence id="5">p16 gene inactivation correlates with adverse prognosis features .</sentence>
<sentence id="6">The patients with p16 inactivation had poor response to chemotherapy , and had significantly shorter survival times than the patients in whom p16 gene was preserved ( P<0.001 ) .</sentence>
<sentence id="7">The inactivation of p16 gene play a key role in the pathogenesis and the progression of some leukemia .</sentence>
<sentence id="8">The detection of p16 gene is reliable prognostic factor that predict shortened survival times .</sentence>